| Ident. | Authors (with country if any) | Title |
|---|
| 000051 (2020) |
Vladimir Khavinson [Russie] ; Natalia Linkova [Russie] ; Anastasiia Dyatlova [Russie] ; Boris Kuznik [Russie] ; Roman Umnov [Russie] | Peptides: Prospects for Use in the Treatment of COVID-19. |
| 000059 (2020) |
Sun-Hyung Ha [Corée du Sud] ; Hyunju Choi [Corée du Sud] ; Jun-Young Park [Corée du Sud] ; Fukushi Abekura [Corée du Sud] ; Young-Choon Lee [Corée du Sud] ; Jeong-Ran Kim [Corée du Sud] ; Cheorl-Ho Kim [Corée du Sud] | Mycobacterium tuberculosis-Secreted Protein, ESAT-6, Inhibits Lipopolysaccharide-Induced MMP-9 Expression and Inflammation Through NF-κB and MAPK Signaling in RAW 264.7 Macrophage Cells. |
| 000061 (2020) |
Muhammad Idrees [Royaume-Uni] ; Afzal R. Mohammad [Royaume-Uni] ; Nazira Karodia [Royaume-Uni] ; Ayesha Rahman [Royaume-Uni] | Multimodal Role of Amino Acids in Microbial Control and Drug Development. |
| 000062 (2020) |
Julie Girouard [Canada] ; Denise Belgorosky [Argentine] ; Jovane Hamelin-Morrissette [Canada] ; Valerie Boulanger [Canada] ; Ernesto D'Orio [Argentine] ; Djamel Ramla [Canada] ; Robert Perron [Canada] ; Lucie Charpentier [Canada] ; Céline Van Themsche [Canada] ; Ana Maria Eiján [Argentine] ; Gervais Bérubé [Canada] ; Carlos Reyes-Moreno [Canada] | Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways. |
| 000067 (2020) |
Safirah Maheen [Pakistan] ; Akhtar Rasul [Pakistan] ; Muhammad Hanif [Pakistan] ; Hafeez Ullah Khan [Pakistan] | Lipospheres for Simultaneous Controlled Release and Improved Pharmacokinetic Profiles of Saxagliptin-Enalapril: Formulation, Optimization, and Comparative In Vitro-In Vivo Evaluation. |
| 000110 (2020) |
Z. Yan [États-Unis] ; M. Huang [États-Unis] ; C. Melander [États-Unis] ; B V Kjellerup [États-Unis] | Dispersal and inhibition of biofilms associated with infections. |
| 000137 (2020) |
Nancy Khardori [États-Unis] ; Cecilia Stevaux [États-Unis] ; Kathryn Ripley [États-Unis] | Antibiotics: From the Beginning to the Future: Part 1. |
| 000282 (2019) |
Dong-Ju Park [Corée du Sud] ; Ju-Bin Kang [Corée du Sud] ; Murad-Ali Shah [Corée du Sud] ; Phil-Ok Koh [Corée du Sud] | Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells. |
| 000321 (2019) |
S. Rogg [Allemagne] ; D H Fuertinger [Allemagne] ; S. Volkwein [Allemagne] ; F. Kappel [Autriche] ; P. Kotanko [États-Unis] | Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach. |
| 000343 (2019) |
Inesa Hadrovic [Allemagne] ; Philipp Rebmann [Allemagne] ; Frank-Gerrit Kl Rner [Allemagne] ; Gal Bitan [États-Unis] ; Thomas Schrader [Allemagne] | Molecular Lysine Tweezers Counteract Aberrant Protein Aggregation. |
| 000458 (2019) |
Ronivaldo Rodrigues Da Silva [Brésil] | Enzyme technology in food preservation: A promising and sustainable strategy for biocontrol of post-harvest fungal pathogens. |
| 000486 (2019) |
G. Aqeele [Iran, Iraq] ; P. Shayan [Iran, Iraq] ; E. Ebrahimzadeh [Iran] ; M. Mohebali [Iran] ; S. Khalili [Iran] | Determination of the Effective Dose of Curcumin alone and in Combination with Antimicrobial Peptide CM11 on Promastigote Forms of Iranian Strain of L. major (MRHO / IR / 75 / ER). |
| 000510 (2019) |
Lian Shu [République populaire de Chine] ; Xiaojing Guo [République populaire de Chine] ; Lili Niu [République populaire de Chine] ; Xiulan Chen [République populaire de Chine] ; Tanxi Cai [République populaire de Chine] ; Xiang Ding [République populaire de Chine] ; Zhensheng Xie [République populaire de Chine] ; Jifeng Wang [République populaire de Chine] ; Nali Zhu [République populaire de Chine] ; Tongxin Kou [République populaire de Chine] ; Fuquan Yang [République populaire de Chine] | Comprehensive characterization and proteoform analysis of the hydrophobic surfactant proteins B and C in calf pulmonary surfactant. |
| 000607 (2019) |
Mugdha Vasireddi [États-Unis] ; Albert Crum [États-Unis] ; Harold May [États-Unis] ; David Katz [États-Unis] ; Julia Hilliard [États-Unis] | A novel antiviral inhibits Zika virus infection while increasing intracellular glutathione biosynthesis in distinct cell culture models. |
| 000624 (2018) |
Yang Yang [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Tantan Gao [République populaire de Chine] ; Yue Zhang [République populaire de Chine] ; Qi Wang [République populaire de Chine] | C-di-GMP turnover influences motility and biofilm formation in Bacillus amyloliquefaciens PG12. |
| 000653 (2018) |
Steffen Hahnel [Allemagne, États-Unis] ; Nic Wheeler [États-Unis] ; Zhigang Lu [Allemagne, Royaume-Uni] ; Arporn Wangwiwatsin [Royaume-Uni] ; Paul Mcveigh [Royaume-Uni] ; Aaron Maule [Royaume-Uni] ; Matthew Berriman [Royaume-Uni] ; Timothy Day [États-Unis] ; Paula Ribeiro [Canada] ; Christoph G. Grevelding [Allemagne] | Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni. |
| 000752 (2018) |
Elena Presas [Irlande (pays)] ; Fiona Mccartney [Irlande (pays)] ; Eric Sultan ; Corina Hunger ; Sabine Nellen ; Clara V Alvarez [Espagne] ; Ulrich Werner ; Didier Bazile ; David J. Brayden [Irlande (pays)] ; Caitriona M. O'Driscoll [Irlande (pays)] | Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin. |
| 000781 (2018) |
Caroline S. Johnson [États-Unis] ; Jaideep S. Bains [Canada] ; Alan G. Watts [États-Unis] | Neurotransmitter diversity in pre-synaptic terminals located in the parvicellular neuroendocrine paraventricular nucleus of the rat and mouse hypothalamus. |
| 000787 (2018) |
Marziyeh Hajialyani [Oman] ; Devesh Tewari [Inde] ; Eduardo Sobarzo-Sánchez [Espagne, Chili] ; Seyed Mohammad Nabavi [Iran] ; Mohammad Hosein Farzaei [Oman] ; Mohammad Abdollahi [Iran] | Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems. |
| 000917 (2018) |
Xiaoying Xing [République populaire de Chine] ; Xiuyun Zhao [République populaire de Chine] ; Jia Ding [République populaire de Chine] ; Dongming Liu [République populaire de Chine] ; Gaofu Qi [République populaire de Chine] | Enteric-coated insulin microparticles delivered by lipopeptides of iturin and surfactin. |
| 000922 (2018) |
Ziyu Kuai [République populaire de Chine] ; Yan Xu [République populaire de Chine] ; Qi Zhao [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Shanshan Guan [République populaire de Chine] ; Yongbo Qiao [République populaire de Chine] ; Xin Gong [République populaire de Chine] ; Jiaojiao Nie [République populaire de Chine] ; Pengju Li [République populaire de Chine] ; Dongni Liu [République populaire de Chine] ; Yifan Xing [République populaire de Chine] ; Huiwen Li [République populaire de Chine] ; Zixiao Sun [République populaire de Chine] ; Wenqi Wang [République populaire de Chine] ; Chunan Ning [République populaire de Chine] ; Yuhua Shi [République populaire de Chine] ; Wei Kong [République populaire de Chine] ; Yaming Shan [République populaire de Chine] | Effects of insulin on transcriptional response and permeability in an in vitro model of human blood-brain barrier. |
